LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

LLY

824.65

+1.39%↑

UNH

499.07

+2.21%↑

JNJ

163.02

+0.06%↑

NVO

80.29

+3.98%↑

ABBV

214.79

+1.37%↑

Search

Accuray Inc

Cerrado

Sector Salud

1.87 2.75

Resumen

Variación precio

24h

Actual

Mínimo

1.8

Máximo

1.88

Métricas clave

By Trading Economics

Ingresos

6.5M

2.5M

Ventas

15M

116M

BPA

0.02

Margen de beneficio

2.184

Empleados

987

EBITDA

8.3M

7.6M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+234.97% upside

Dividendos

By Dow Jones

Próximas Ganancias

30 abr 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-48M

191M

Apertura anterior

-0.88

Cierre anterior

1.87

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

Accuray Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

17 mar 2025, 23:30 UTC

Acciones populares

Stocks to Watch: Harrow, Bakkt Holdings, Alphabet

17 mar 2025, 23:59 UTC

Charlas de Mercado

More Time Needed to Form View on NAB's New Hire -- Market Talk

17 mar 2025, 23:43 UTC

Charlas de Mercado

Nikkei May Rise as Fears About U.S. Tariffs Recede -- Market Talk

17 mar 2025, 23:43 UTC

Ganancias

Smoore International: New Products Expected to Present More Opportunities for Rev Growth >6969.HK

17 mar 2025, 23:43 UTC

Ganancias

Smoore International: Will Introduce More Innovative Products to Meet Evolving Consumer Demands >6969.HK

17 mar 2025, 23:42 UTC

Ganancias

Smoore International: Rev Mainly From Corporate Client Oriented Business, Self-Branded Business >6969.HK

17 mar 2025, 23:39 UTC

Ganancias

Smoore International 2024 Net CNY1.30B Vs. Net CNY1.645B >6969.HK

17 mar 2025, 23:39 UTC

Ganancias

Smoore International 2024 Rev CNY11.80B Vs. CNY11.20B >6969.HK

17 mar 2025, 23:17 UTC

Charlas de Mercado

BlackRock Jittery About Outlook for US Bond Yields -- Market Talk

17 mar 2025, 23:01 UTC

Charlas de Mercado

Williams Cos. Seen as Company With Most 'Shots on Goal' in Natural Gas Space -- Market Talk

17 mar 2025, 23:00 UTC

Principales Noticias

Santander Pushes to Expand U.S. Operations by Utilizing Verizon Customer Base -- WSJ

17 mar 2025, 22:29 UTC

Ganancias

WuXi AppTec: Impairment Losses, Higher Finance Costs Among Factors Affecting Net>603259.SH

17 mar 2025, 22:29 UTC

Ganancias

WuXi AppTec Board Announces Special Dividend of CNY3.50 For Every 10 Shares Held >603259.SH

17 mar 2025, 22:29 UTC

Ganancias

WuXi AppTec 2024 Net CNY9.35B Vs. Net CNY10.69B >603259.SH

17 mar 2025, 22:29 UTC

Ganancias

WuXi AppTec 2024 Rev CNY39.24B Vs. CNY40.34B >603259.SH

17 mar 2025, 22:24 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Google in Fresh Talks to Buy Cybersecurity Startup Wiz for $30 Billion -- 2nd Update

17 mar 2025, 22:16 UTC

Adquisiciones, fusiones, absorciones

Microsoft: Expresses No Opinion and Is Neutral on TRC's Offer >MSFT

17 mar 2025, 22:15 UTC

Adquisiciones, fusiones, absorciones

Microsoft: Not Affiliated With TRC, Doesn't Endorse Offer Documentation or Offer Itself >MSFT

17 mar 2025, 22:14 UTC

Adquisiciones, fusiones, absorciones

Microsoft Responds to TRC Capital's 'Mini-Tender' Offer

17 mar 2025, 21:19 UTC

Principales Noticias

Stocks Haven't Traded at These Levels Since September -- Update

17 mar 2025, 21:12 UTC

Adquisiciones, fusiones, absorciones

Google Restarts Acquisition Talks With Cybersecurity Firm Wiz -- IBD

17 mar 2025, 20:54 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Google in Fresh Talks to Buy Cybersecurity Startup Wiz for $30 Billion -- Update

17 mar 2025, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

17 mar 2025, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

17 mar 2025, 20:26 UTC

Charlas de Mercado

Gold Settles at Record $3,000/oz -- Market Talk

17 mar 2025, 20:24 UTC

Principales Noticias

Dow Rises Nearly 1%, Building on Friday's Gains -- WSJ

17 mar 2025, 20:15 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Global Commodities Roundup: Market Talk

17 mar 2025, 20:09 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Pepsi's Poppi Deal Attractive, With International Sales Potential -- Market Talk

17 mar 2025, 20:03 UTC

Principales Noticias
Adquisiciones, fusiones, absorciones

Alphabet Back in Deal Talks for Cybersecurity Startup Wiz -- WSJ

17 mar 2025, 19:25 UTC

Charlas de Mercado

Mark Carney's Liberals Pull Ahead in Latest Canada Polling -- Market Talk

Comparación entre iguales

Cambio de precio

Accuray Inc Esperado

Precio Objetivo

By TipRanks

234.97% repunte

Estimación a 12 meses

Media 6.13 USD  234.97%

Máximo 7 USD

Mínimo 5.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Accuray Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

1.82 / 1.91Soporte y Resistencia

Corto Plazo

Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.